1222074-03-4 Usage
Description
(S)-(-)-2-(N-propylamino)-5-methoxytetraline (+)-N-(3,5-dinitrobenzoyl)-α-phenylglycine salt is a complex chemical compound consisting of two distinct components: (S)-(-)-2-(N-propylamino)-5-methoxytetraline, a specific enantiomer of a tetraline derivative with a propylamino and methoxy group, and (+)-N-(3,5-dinitrobenzoyl)-α-phenylglycine, a salt form of N-(3,5-dinitrobenzoyl)-α-phenylglycine. (S)-(-)-2-(N-propylamino)-5-methoxytetraline (+)-N-(3,5-dinitrobenzoyl)-α-phenylglycine salt is characterized by its unique structural and functional properties, which may have potential applications in various fields such as pharmaceuticals, biochemistry, and organic chemistry.
Uses
Used in Pharmaceutical Industry:
(S)-(-)-2-(N-propylamino)-5-methoxytetraline (+)-N-(3,5-dinitrobenzoyl)-α-phenylglycine salt is used as a potential therapeutic agent for [application reason] due to its unique structural properties and potential interactions with biological targets.
Used in Biochemical Research:
In the field of biochemistry, (S)-(-)-2-(N-propylamino)-5-methoxytetraline (+)-N-(3,5-dinitrobenzoyl)-α-phenylglycine salt is used as a research tool for [application reason], such as studying enzyme inhibition, receptor binding, or other biological processes.
Used in Organic Chemistry:
(S)-(-)-2-(N-propylamino)-5-methoxytetraline (+)-N-(3,5-dinitrobenzoyl)-α-phenylglycine salt is utilized as a synthetic building block or intermediate for [application reason] in the synthesis of more complex organic molecules or pharmaceutical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1222074-03-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,2,0,7 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1222074-03:
(9*1)+(8*2)+(7*2)+(6*2)+(5*0)+(4*7)+(3*4)+(2*0)+(1*3)=94
94 % 10 = 4
So 1222074-03-4 is a valid CAS Registry Number.
1222074-03-4Relevant articles and documents
PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE (S)-(-)-2-(N-PROPYLAMINO)-5-METHOXYTETRALINE AND (S)-(-)-2-(N-PROPYLAMINO)-5-HYDROXYTETRALINE COMPOUNDS
-
Page/Page column 3, (2011/07/06)
The present invention describes a novel process for the preparation of optically active (S)-(?)-2-(N-propylamino)-5-methoxytetraline and (S)-(?)-2-(N-propylamino)-5-hydroxytetraline compounds based on the optical resolution of mixtures of the enantiomers of 2-(N-propylamino)-5-methoxytetraline and 2-(N-propylamino)-5-hydroxytetraline respectively. This process comprises (a) reacting a mixture of the enantiomers of said compounds with an optically active organic acid to form diastereoisomeric salts and separating the salts by crystallization. Said compounds are useful in the preparation of (6S)-(?)-5,6,7,8-tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthol (Rotigotine). Rotigotine is a dopamine agonist and is indicated for the treatment of Parkinson's disease.
